Skip to main content

DAFNA Capital Management LLC

Position in LRMR — Larimar Therapeutics, Inc.

CIK 1389933 LOS ANGELES, CA

Position in LRMR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$9,131,238
+$5,553,024 QoQ
Shares Held
2,029,164
+116.1% QoQ
Ownership
1.95%
of shares outstanding
% of Portfolio
2.39%
of 13F equity value
Holder Rank
#8
of 161 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LRMR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DAFNA Capital Management LLC holds $266,664,368 across 58 Biotechnology names. LRMR ranks #8 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 LRMR
Larimar Therapeutics, Inc.
This page
2,029,164 $9,131,238

All Filings in LRMR

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,131,238 2,029,164
2025-12-31 $3,578,214 939,164
2025-09-30 $3,319,677 1,027,764
2025-06-30 $1,073,444 371,434
2025-03-31 $798,583 371,434
2024-12-31 $1,437,449 371,434
2024-09-30 $3,237,494 494,274
2024-06-30 $4,639,811 639,974
2024-03-31 $4,981,871 656,373
2023-12-31 $1,473,622 323,873
2023-09-30 $1,293,123 327,373
2023-06-30 $1,096,667 350,373
2023-03-31 $1,073,034 236,873
2022-12-31 $1,954,051 473,136
2022-09-30 $1,839,987 574,996
2022-06-30 $97,992 49,996
2022-03-31 $202,483 49,996
2021-12-31 $757,209 70,177
2021-09-30 $743,535 64,487
2021-06-30 $756,012 76,987
2021-03-31 $1,189,721 81,432
2020-12-31 $1,036,843 48,428
2020-09-30 $1,200,781 79,155
2020-06-30 $1,622,453 126,261